Keith Charles Deen

Title: The Innovations of Keith Charles Deen

Introduction

Keith Charles Deen is a notable inventor based in Glenmoore, PA (US). He has made significant contributions to the field of medical science, particularly in the development of treatments for various diseases. With a total of 4 patents to his name, Deen's work has the potential to impact many lives.

Latest Patents

One of Deen's latest patents involves the Tumor Necrosis Related Receptor, TR7. This patent discloses TR7 polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. The applications of TR7 polypeptides and polynucleotides are extensive, including the design of protocols for treating chronic and acute inflammation, arthritis, septicemia, autoimmune diseases, transplant rejection, and various cancers, among others. Additionally, diagnostic assays for these conditions are also part of his innovative work.

Career Highlights

Deen is currently associated with SmithKline Beecham Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize treatment protocols in the medical field.

Collaborations

Throughout his career, Deen has collaborated with esteemed colleagues such as Peter R Young and Kong B Tan. These partnerships have further enriched his research and contributed to the success of his innovations.

Conclusion

Keith Charles Deen's contributions to medical science through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treatment protocols for various diseases.